Details

A 15-year experience highlighting the spectrum of Alport kidney disease in the pediatric population and novel genetic variants in COL4A3–5
ID Andrejašič, Nastja (Author), ID Blejc Novak, Anja (Author), ID Močnik, Mirjam (Author), ID Marčun-Varda, Nataša (Author), ID Stangler Herodež, Špela (Author), ID Krgović, Danijela (Author), ID Zupan, Andrej (Author), ID Meglič, Anamarija (Author)

.pdfPDF - Presentation file, Download (896,33 KB)
MD5: CE10BF298A881D70746F3D25A873B58E
URLURL - Source URL, Visit https://link.springer.com/article/10.1007/s00467-025-06683-8 This link opens in a new window

Abstract
Background Alport kidney disease (AKD) presents one of the most prevalent genetic kidney disorders, characterized by a complex genetic background and diverse clinical manifestations. This study aimed to review the clinical and genetic features of pediatric patients with COL4A3–5 variants and identify novel genetic variants. Methods Data were collected retrospectively at a national level from pediatric patients up to 19 years old, who underwent genetic testing between 2008 and 2023. Patients with pathogenic and likely pathogenic COL4A3–5 variants were included. Their clinical, laboratory, and genetic characteristics were presented. Results Over 15 years, 85 children and adolescents tested positive for pathogenic or likely pathogenic COL4A3–5 variants. Increasing incidence was noted as genetic testing became more prevalent. One patient (1.2%) progressed to kidney failure and six (7%) had extrarenal involvement. Pathogenic or likely pathogenic variants in COL4A3, COL4A4, and COL4A5 genes were found in 14 (16.4%), 34 (40.0%), and 37 (43.6%) patients, respectively. Patients were diagnosed with autosomal, X-linked, and digenic AKD in 55.2%, 43.6%, and 1.2%, respectively. Eight novel variants were recorded, and their associated phenotype presented. Conclusions This study expands the genetic and clinical background of pediatric patients with AKD, presenting on a spectrum from mild hematuria to progressive chronic kidney disease. Genetic confirmation and risk stratification in the pediatric population are critical to ensure timely care and potentially slow down the progression of kidney disease.

Language:English
Keywords:Alport kidney disease, children, phenotype, genotype, COL4A3–5, hereditary nephritis, kidney diseases
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2025
Number of pages:Str. 2215–2223
Numbering:Vol. 40, iss. 7
PID:20.500.12556/RUL-169429 This link opens in a new window
UDC:616.6
ISSN on article:1432-198X
DOI:10.1007/s00467-025-06683-8 This link opens in a new window
COBISS.SI-ID:225255171 This link opens in a new window
Publication date in RUL:28.05.2025
Views:566
Downloads:151
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Pediatric nephrology
Shortened title:Pediatr. nephrol.
Publisher:Springer Nature
ISSN:1432-198X
COBISS.SI-ID:513718041 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P3-0054
Name:Patologija in molekularna genetika

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back